Royal Bank of Canada
CRTX

Royal Bank of Canada’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Royal Bank of Canada’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-19,156
Closed -$182K – 6437
2013
Q4 		$182K Sell
19,156
-4,328
-18% -$41K ﹤0.01% 4234
2013
Q3 		$220K Buy
23,484
+23,454
+78,180% +$211K ﹤0.01% 4028
2013
Q2 		$0 Buy
+30
New +$253 ﹤0.01% 5926

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Royal Bank of Canada's CRTX Position: Q1 2014 in Review

Royal Bank of Canada sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 19,156 shares — an estimated $182K sold.

Royal Bank of Canada first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $220K in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Royal Bank of Canada reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 19,156 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $182K.
  • Royal Bank of Canada first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Royal Bank of Canada's CORNERSTONE THERAPEUTICS INC position peaked at $220K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Royal Bank of Canada's 13F filing for Q1 2014, filed 15 May 2014.